---
title: "Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286616590.md"
description: "The Law Offices of Frank R. Cruz has announced an investigation into Zoetis Inc. (ZTS) for potential violations of federal securities laws following a significant drop in share price. On May 7, 2026, Zoetis reported flat net income of $601 million and lowered its profit guidance for the year, leading to a 21.50% decline in share price. Shareholders who lost money are encouraged to contact the law firm for potential claims."
datetime: "2026-05-15T21:10:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286616590.md)
  - [en](https://longbridge.com/en/news/286616590.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286616590.md)
---

# Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

**Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz**

The Law Offices of Frank R. Cruz announces an investigation of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

**IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZOETIS INC. (ZTS), CLICK** **HERE** **TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.**

**What Is The Investigation About?**

On May 7, 2026, Zoetis reported financial results for the first quarter of 2026. Among other items, Zoetis reported net income of $601 million, flat year over year, and cuts to its full year 2026 profit guidance to between $6.85 and $7 a share, down from prior guidance of $7.00 to $7.10 a share. CEO Kristin Peck said in the earnings release “**_the first quarter unfolded in a more challenging operating environment than we anticipated. Pet owners demonstrated increased price sensitivity, resulting in a decline in veterinary visits and softer demand_**\[.\]”

On this news, the price of Zoetis shares declined by $23.91 per share, or 21.50%, to close at $87.31 on May 7, 2026.

**Contact Us to Participate or Learn More:**

If you purchased Zoetis securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz  
2121 Avenue of the Stars, Suite 800  
Century City, California 90067  
Call us at: 310-914-5007  
Email us at: info@frankcruzlaw.com  
Visit our website at: www.frankcruzlaw.com.  
Follow us for updates on Twitter at twitter.com/FRC\_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz, Los Angeles  
Frank R. Cruz  
310-914-5007  
fcruz@frankcruzlaw.com  
www.frankcruzlaw.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260515601989/en/

### Related Stocks

- [ZTS.US](https://longbridge.com/en/quote/ZTS.US.md)

## Related News & Research

- [Zoetis (ZTS) Valuation Check After Rare Q1 2026 Miss And Cut To Full Year Guidance](https://longbridge.com/en/news/286140773.md)
- [Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation](https://longbridge.com/en/news/286800814.md)
- [Major Purchase Alert: MICHAEL MCCALLISTER Invests $233K In Zoetis Stock](https://longbridge.com/en/news/286283898.md)
- [Zoetis Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/285962446.md)
- [Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C. | CMND Stock News](https://longbridge.com/en/news/286566409.md)